The latest biotech news

News and Trends 29 Sep 2014

How to Save Thousands of Lives Thanks to Tuberculosis Test Fitting in your Pocket?

The EU-funded POCKET project is developing a low-cost urine test that can quickly detect tuberculosis (TB), a preventable disease that kills nearly 2 million people every year. Started in November 2013, the initiative already started and develops a low-cost urine test that will make TB detection accessible to all. Right now, researchers working on POCKET […]

September 29, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 26 Sep 2014

An Innovative Test to Detect Colon Cancer on Time

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three organizations will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers. The three structures will work closely together to develop the in-vitro diagnostic test […]

September 26, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 25 Sep 2014

A New Financial Hope for Start-ups Focused on Cancer

Aglaia is a new venture capital fund that will invest in about ten to fifteen biotechnology start-ups developing groundbreaking technologies to prevent and cure cancer. The Dutch venture has announced the launch of Aglaia Oncology Fund II. Investors contribute with $65M (EUR 51M) for the fund, to reach $80M (EUR 63M) to $100M (EUR 80M). Like […]

September 25, 2014 - 2 minutesmins - By Julie Lellouche

Kao research identifies natural enzyme to produce sustainable surfactants strict xxl

News and Trends 24 Sep 2014

Natural Cosmetics thanks to Enzymes?

A 7 million euros European-funded project has been launched with the intention of replacing chemical cosmetic production techniques with eco-friendly alternatives. This is the OPTIBIOCAT project which wants to provide technical improvement to the natural cosmetics sector, required to satisfy consumer demand for natural and ecological products. Building on a diverse consortium of 16 partners from […]

September 24, 2014 - 2 minutesmins - By Julie Lellouche

Carmat polemic intelligent artificial heart

News and Trends 24 Sep 2014

The Polemic of First Intelligent Artificial Heart

The first intelligent artificial heart has been twice implanted in France within clinical trials. It has been developed by French company Carmat, and famous cardiologist Alain Carpentier, after 20 years of development. This important breakthrough nevertheless create a polemic. Artificial hearts already existed and voice talks about an artificial financial bubble around Carmat. On September 11th, […]

September 24, 2014 - 4 minutesmins - By Joachim Eeckhout

News and Trends 22 Sep 2014

Is a new revolution in lung cancer drug treatment coming ?

A new revolutionary treatment could help cure lung cancer. It is based on mRNA instead of antibodies and chemotherapy. Instead of delivering the protein or the drug, only a message is delivering and the body will produce the therapeutics. Curevac, the historic and one of the leading Biotech company in this field announced a 465 million […]

September 22, 2014 - 3 minutesmins - By Philip Hemme

Presentation www.labiotech.eu Betahaus 2 long

News and Trends 19 Sep 2014

Public launch of LaBiotech.eu at Betahaus Berlin

Hello everyone, Yesterday, we publicly launched LaBiotech.eu at Betahaus Berlin, the biggest co-working space of the city. It was the big day for the third project of LaBiotech Group after LaBiotech.fr, the leading French biotech news website, and LaBiotech Tour, the first World Tour of Biotech ecosystem. Europe had until now several well-established printed newspaper […]

September 19, 2014 - 1 minutemin - By Philip Hemme

News and Trends 18 Sep 2014

Would you be interested by MinION, the first pocket DNA sequencer ?

The first next-gen sequencing device of the size of an iPhone has been shipped. It is called MinION and is developed by the Oxford-based company Nanopore technologies. The long research and development process has finally paid off. How can a next-gen sequencer hold in a so small device? It uses a newly developed nanopore sequencing method. […]

September 18, 2014 - 3 minutesmins - By Philip Hemme

Sophia Genetics is the first European bioinformatic company allowed to analyze clinical genetic data

News and Trends 17 Sep 2014

Sophia Genetics: the first European bioinformatic company allowed to analyze clinical genetic data

Sophia Genetics has become the first European company to obtain a CE-IVD mark allowing the use of their bioinformatic algorithms to analyse clinical data obtained through Next Generation Sequencing. This certification is an important step in making these in the standard use of routine genetic testing and clinical diagnosis. It brings Sophia Genetics’ world-leading Data Driven Medicine platform to […]

September 17, 2014 - 2 minutesmins - By Julie Lellouche

Eli Lilly and Boehringer Ingelheim’s product the first insulin biosimilar approved in Europe2

News and Trends 16 Sep 2014

The first insulin biosimilar has been approved in Europe

The European Commission granted marketing authorisation to Eli Lilly and Company and Boehringer Ingelheim for the first insulin biosimilar glargine product. It is indicated to treat diabetes in adults, adolescents and children aged 2 years and above. The collaboration between the two companies is bearing fruit, it is the first-ever version of this class. It received […]

September 16, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 4 Sep 2014

Art Levinson says goodbye to Roche and will focus on Calico’s development

Roche announced today that Arthur D. Levinson has resigned from the Board of Directors, effective immediately. Arthur D. Levinson made this decision so as to avoid any conflict of interest given his role as Chief Executive Officer at Calico. “I would like to thank Art for his many important contributions, both as a member […]

September 4, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 3 Sep 2014

Affimed secures almost $30M in Financing to continue its clinical development

Affimed Therapeutics today announced that it has closed a $15.7 million (€11.7 million) Series E equity funding led by Affimed’s current investors Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S and Orbimed. In addition, the Company has signed a $14 million (€10.5 million) loan agreement with Perceptive Advisors, leading to a total of […]

September 3, 2014 - 2 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

How to Save Thousands of Lives Thanks to Tuberculosis Test Fitting in your Pocket?

An Innovative Test to Detect Colon Cancer on Time

A New Financial Hope for Start-ups Focused on Cancer

Natural Cosmetics thanks to Enzymes?

The Polemic of First Intelligent Artificial Heart

Is a new revolution in lung cancer drug treatment coming ?

Public launch of LaBiotech.eu at Betahaus Berlin

Would you be interested by MinION, the first pocket DNA sequencer ?

Sophia Genetics: the first European bioinformatic company allowed to analyze clinical genetic data

The first insulin biosimilar has been approved in Europe

Art Levinson says goodbye to Roche and will focus on Calico’s development

Affimed secures almost $30M in Financing to continue its clinical development

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!